Novel Insights into Genetics of Arterial Thrombosis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-84996-471-5_21
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• [The Rotterdam study].

  2011cited by this paper
• The Functional Promoter Polymorphism of the Coagulation Factor XII Gene is not Associated With Peripheral Arterial Disease

  2010cited by this paper
• Platelet glycoprotein GP VI 13254C allele is an independent risk factor of premature myocardial infarction.

  2010cited by this paper
• Inhibitors of platelet adhesion.

  2009cited by this paper
• Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome.

  2009cited by this paper
• Platelet receptors and signaling in the dynamics of thrombus formation

  2009cited by this paper
• Protein S as Cofactor for TFPI

  2009cited by this paper
• Prothrombotic genetic variants and atherosclerosis in patients with cerebral ischemia of arterial origin.

  2009cited by this paper
• The Antiangiogenic Activity of rPAI-123 Inhibits Vasa Vasorum and Growth of Atherosclerotic Plaque

  2009cited by this paper
• Is thrombin a key player in the 'coagulation-atherogenesis' maze?

  2009cited by this paper
• Dual role of collagen in factor XII-dependent thrombus formation.

  2009cited by this paper
• Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke

  2009cited by this paper
• Hypercoagulability Inhibits Monocyte Transendothelial Migration Through Protease-Activated Receptor-1–, Phospholipase-Cβ–, Phosphoinositide 3-Kinase–, and Nitric Oxide–Dependent Signaling in Monocytes and Promotes Plaque Stability

  2009cited by this paper
• The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study 1

  2009cited by this paper
• Polymorphism FXII 46C>T and cardiovascular risk: additional data from Spanish and Tunisian patients

  2009cited by this paper
• Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.

  2009cited by this paper
• Are Prothrombotic Variants of Platelet Glycoprotein Receptor Polymorphisms Involved in the Pathogenesis of Thrombotic Microangiopathies?

  2009cited by this paper
• Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

  2009cited by this paper
• Platelet collagen receptors, signaling and antagonism: emerging approaches for the prevention of intravascular thrombosis.

  2008cited by this paper
• Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years

  2008cited by this paper
• Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes

  2008cited by this paper
• Plasminogen Activator Inhibitor-1 Polymorphism (4G/5G) Predicts Recurrence in Nonhyperlipidemic Postinfarction Patients

  2008cited by this paper
• Cell Adhesion Mechanisms in Platelets

  2008cited by this paper
• Association of β-fibrinogen gene −148C/T and −455G/A polymorphisms and coronary artery disease in Chinese population: A Meta analysis

  2008cited by this paper
• Reduced incidence of ischemic stroke in patients with severe factor XI deficiency.

  2008cited by this paper
• Hereditary Deficiency of Protein C or Protein S Confers Increased Risk of Arterial Thromboembolic Events at a Young Age: Results From a Large Family Cohort Study

  2008cited by this paper
• Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk

  2008cited by this paper
• Prothrombotic Gene Variation in Patients with Large and Small Vessel Disease

  2008cited by this paper
• Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice

  2008cited by this paper
• Polymorphisms in Platelet Glycoprotein 1bα and Factor VII and Risk of Ischemic Stroke: A Meta-Analysis

  2008cited by this paper
• The influence of metabolic syndrome components on plasma PAI-1 concentrations is modified by the PAI-1 4G/5G genotype and ethnicity.

  2008cited by this paper
• Rare inherited disorders of fibrinogen

  2008cited by this paper
• Fibrinogen &ggr;′ in Ischemic Stroke: A Case-Control Study

  2008cited by this paper
• Combined Effect of Hemostatic Gene Polymorphisms and the Risk of Myocardial Infarction in Patients with Advanced Coronary Atherosclerosis

  2008cited by this paper
• The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis.

  2008cited by this paper
• Ischaemic Stroke Subtypes and Their Genetic Basis: A Comprehensive Meta-Analysis of Small and Large Vessel Stroke

  2008cited by this paper
• Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke.

  2008cited by this paper
• Fibrinogen gamma in ischemic stroke: a case-control study

  2007cited by this paper
• The PAI-1 4G/5G gene polymorphism and ischemic stroke: an association study and meta-analysis.

  2007cited by this paper
• ABO ( H ) blood groups and vascular disease : a systematic review and meta-analysis

  2007cited by this paper
• Factor XIII Val34Leu variant and the risk of myocardial infarction

  2007cited by this paper
• Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and coronary artery disease: a meta-analysis.

  2007cited by this paper
• The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption

  2007cited by this paper
• Integrin, alpha 2 gene C807T polymorphism and risk of ischemic stroke: a meta-analysis.

  2007cited by this paper
• Elevated plasma fibrinogen γ′ concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors

  2007cited by this paper
• Type IIB von Willebrand Disease: Role of Qualitative Defects in Atherosclerosis and Endothelial Dysfunction

  2007cited by this paper
• Factor XIII Val34Leu variant protects against coronary artery disease

  2007cited by this paper
• Platelet activation and atherothrombosis.

  2007cited by this paper
• The plasma kallikrein–kinin system and risk of cardiovascular disease in men

  2007cited by this paper
• Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV.

  2007cited by this paper
• Fibrinolysis and the risk of venous and arterial thrombosis

  2007influential reference
• Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.

  2006cited by this paper
• Tissue Factor and Coagulation Factor VII Levels During Acute Myocardial Infarction: Association With Genotype and Adverse Events

  2006cited by this paper
• The association between factor XIII Val34Leu polymorphism and early myocardial infarction.

  2006cited by this paper
• An Effect of the PAI-1 4G/5G Polymorphism on Cholesterol Levels May Explain Conflicting Associations with Myocardial Infarction and Stroke

  2006cited by this paper
• The Effects of Three Factor VII Polymorphisms on Factor VII Coagulant Levels in Healthy Singaporean Chinese, Malay and Indian Newborns

  2006cited by this paper
• The 4G/5G PAI‐1 polymorphism influences the endothelial response to IL‐1 and the modulatory effect of pravastatin

  2006cited by this paper
• Polyphosphate modulates blood coagulation and fibrinolysis.

  2006cited by this paper
• Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls.

  2006influential reference
• Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review

  2006cited by this paper
• No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factors

  2005cited by this paper
• Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.

  2005cited by this paper
• Genetic Variations in the Tissue Factor Gene Are Associated With Clinical Outcome in Acute Coronary Syndrome and Expression Levels in Human Monocytes

  2005cited by this paper
• Defective thrombus formation in mice lacking coagulation factor XII

  2005cited by this paper
• Interaction between factor V Leiden and serum LDL cholesterol increases the risk of atherosclerosis.

  2005cited by this paper
• The molecular physiology and pathology of fibrin structure/function.

  2005cited by this paper
• Fibrinolytic Gene Polymorphism and Ischemic Stroke

  2005cited by this paper
• A novel polymorphism in the factor XIII B‐subunit (His95Arg): relationship to subunit dissociation and venous thrombosis

  2005cited by this paper
• Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefact

  2005cited by this paper
• TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study

  2005cited by this paper
• Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarction

  2005cited by this paper
• Myocardial Infarction and Arterial Thrombosis in Severe (Homozygous) FXII Deficiency: No Apparent Causative Relation

  2005cited by this paper
• Homozygosity for Factor V Leiden Leads to Enhanced Thrombosis and Atherosclerosis in Mice

  2005cited by this paper
• Association study of the thrombomodulin -33G>A polymorphism with coronary artery disease and myocardial infarction in Chinese Han population.

  2005cited by this paper
• Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

  2005cited by this paper
• Thrombophilic risk factors in patients with severe carotid atherosclerosis

  2005cited by this paper
• The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individuals.

  2005cited by this paper
• EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro.

  2005cited by this paper
• Genetic and environmental influences on the fibrinolytic system: a twin study

  2004cited by this paper
• Thr325Ile polymorphism of the TAFI gene is related to TAFI antigen plasma levels and angiographic restenosis after percutaneous coronary interventions.

  2004cited by this paper
• Tissue plasminogen activator antigen and coronary heart disease Prospective study and meta-analysis

  2004cited by this paper
• Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk

  2004cited by this paper
• Thrombomodulin Ala455Val Polymorphism and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study

  2004cited by this paper
• Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart Disease

  2004influential reference
• Genetic variability of von Willebrand factor and atherosclerosis.

  2004cited by this paper
• Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis

  2004cited by this paper
• Homozygosity of the T allele of the 46 C-->T polymorphism in the F12 gene is a risk factor for acute coronary artery disease in the Spanish population.

  2004cited by this paper
• Plasma fibrinogen and factor VII as risk factors for cardiovascular disease

  2004cited by this paper
• The – 148 C/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case–control study

  2004cited by this paper
• Activated factor 12 (FXIIa) predicts recurrent coronary events after an acute myocardial infarction.

  2004cited by this paper
• Genetic variability of von Willebrand factor and risk of coronary heart disease: the Rotterdam Study

  2004cited by this paper
• Genetic and Environmental Determinants of Fibrin Structure and Function: Relevance to Clinical Disease

  2004influential reference
• Homozygosity of the T Allele of the 46 C→T Polymorphism in the F12 Gene Is a Risk Factor for Ischemic Stroke in the Spanish Population

  2004cited by this paper
• Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction.

  2004cited by this paper
• Platelet membrane collagen receptor glycoprotein VI polymorphism is associated with coronary thrombosis and fatal myocardial infarction in middle-aged men.

  2004cited by this paper
• Patients With Type 3 Severe von Willebrand Disease Are Not Protected Against Atherosclerosis: Results From a Multicenter Study in 47 Patients

  2004cited by this paper
• Influence of &ggr;′ Fibrinogen Splice Variant on Fibrin Physical Properties and Fibrinolysis Rate

  2004cited by this paper
• A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide

  2004cited by this paper
• Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia.

  2003cited by this paper
• A meta‐analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart disease

  2003cited by this paper

• The role of coagulation factor XII in fibrin clot formation and fibrinolysis

  2014cites this paper
• The hemostatic system as a modulator of atherosclerosis.

  2011cites this paper